STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Aug. 31, 2019	Aug. 31, 2018
Consolidated Statements Of Operations
Revenue
Operating expenses
Selling, general and administrative	4,431,643	3,622,367
Research and product development	1,979,222	1,931,216
Total operating expenses	6,410,865	5,553,583
Loss from operations	(6,410,865)	(5,553,583)
Other income (expense)
Interest income	315,344
Gain on disposal of assets		326
Interest expense	(128,239)	(477,566)
Accretion of debt discount	(663,918)	(823,724)
Total other income (expense)	(476,813)	(1,300,964)
Net loss	$ (6,887,678)	$ (6,854,547)
Basic and Diluted Loss per Common Share	$ (0.14)	$ (0.19)
Weighted average number of common shares outstanding - basic and diluted	48,986,720	36,020,453